The genetic basis of melanoma development is fairly well understood, with activating mutations in the oncogene BRAF occurring in a majority of melanoma patient tumors (Hodis et al., 2012), which also harbor hundreds of secondary mutations of unknown impact. This evidence concerns the gene BRAF and melanoma.